Comparison of the effect of Listerine mouthwash with chlorhexidine on healing and pain after mandibular impact wisdom tooth surgery

Comparison of efficacy of Listerine mouthwash with chlorhexidine on healing and pain after surgical removal of impacted mandibular third molars

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20171216037893N7

Enrollment

Registered

2021-12-25

Start date

2021-12-12

Completion date

Unknown

Last updated

2022-01-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

healing and pain after surgical removal of impacted mandibular third molars. Encounter for surgical aftercare following surgery on the teeth or oral cavity

Interventions

Intervention 1: Intervention group: Before start the operation, 15 cc of LISTERINE® Cool Mint(ANTISEPTIC) 250ml mouthwash will be administered to wash their mouths with it for 1 minute. Patients must

Eligibility

Sex/Gender

All

Age

18 Years to 50 Years

Inclusion criteria

Inclusion criteria: Having a mandibular third molar degree of surgery difficulty (A,B) (Pell and Gregory) Being between 18-50 years old Non smoker

Exclusion criteria

Exclusion criteria: Having systemic diseases Medication (antipsychotic, anticoagulants, antibiotics and analgesics) Need for antibiotic prophylaxis (such as immunosuppressed patients) Having an infection Any type of bone pathology History of radiotherapy Having painful conditions (having teeth with indication for root canal treatment) Prohibition of surgery for any reason Pregnancy or breastfeeding Allergy to lidocaine or mouthwashes Alcohol and opioid addiction

Design outcomes

Primary

Measure	Time frame
Intensity of pain. Timepoint: Before taking the first analgesic after surgery. Method of measurement: Visual Analogue Scale (VAS).	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactHamidreza Mahaseni aghdam

Islamic Azad University

h_mahaseni@dentaliau.ac.ir+98 21 2240 6440

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026